Raltegravir potassium

Catalog No. A21403

Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection.

Technical details

Catalog Num	A21403
M. Wt	444.42
Formula	C20H21FN6O5
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	871038-72-1
Synonyms	MK-0518 potassium, MK0518, MK 0518
SMILES	O=C(C(O)=C(C(NCC1=CC=C(C=C1)F)=O)N=C2C(C)(C)NC(C3=NN=C(C)O3)=O)N2C

Biological Activity

Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection.

Solubility *

In vitro	DMSO	91 mg/mL (188.59 mM)
	Water	Insoluble
	Ethanol	10 mg/mL (20.72 mM)
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	22.5 mL	112.51 mL	225.01 mL
0.5 mM	4.5 mL	22.5 mL	45 mL
1 mM	2.25 mL	11.25 mL	22.5 mL
5 mM	0.45 mL	2.25 mL	4.5 mL

*The above data is based on the productmolecular weight 444.42. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Adooq Bioscience

Raltegravir potassium

Technical details

Biological Activity

Solubility *

Preparing Stock Solutions